Evidence map›Paper›PMID 34413877›Full record

ArticleFrontiers in genetics2021

A

Jin Zhang, Weiting Tang, Nidhi K Bhatia, Yuchen Xu, Nabina Paudyal, Ding Liu, Sukhan Kim, Rui Song, Wenshu XiangWei, Gil Shaulsky and 6 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Protein quality control ofFrontiers in cellular neuroscience · 2022
    Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Jin ZhangDepartment of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA, United States.
Weiting TangDepartment of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA, United States.
Nidhi K BhatiaDepartment of Biochemistry and Molecular Biology, The University of Texas Health Science Center, Houston, TX, United States.
Yuchen XuDepartment of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA, United States.
Nabina PaudyalDepartment of Biochemistry and Molecular Biology, The University of Texas Health Science Center, Houston, TX, United States.
Ding LiuDepartment of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA, United States.
Sukhan KimDepartment of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA, United States.
Rui SongDepartment of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA, United States.
Wenshu XiangWeiDepartment of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA, United States.
Gil ShaulskyDepartment of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA, United States.
Scott J MyersDepartment of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA, United States.
William DobynsCenter for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, United States.
Vasanthi JayaramanDepartment of Biochemistry and Molecular Biology, The University of Texas Health Science Center, Houston, TX, United States.
Stephen F TraynelisDepartment of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA, United States.
Hongjie YuanDepartment of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA, United States.
Xiuhua BozarthCenter for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, United States.
Emory University · USThe University of Texas Health Science Center at Houston · USCentral South University · CNUniversity of Washington · US

Funding

HOUSTON AREA MOLECULAR BIOPHYSICS TRAINING PROGRAMT32GM008280 · NIGMS · RICE UNIVERSITY · PI WENSEL, THEODORE G · 1988 to 2023
$8.0M
Glutamate receptors and human neurological diseaseR35NS111619 · NINDS · EMORY UNIVERSITY · PI Stephen F Traynelis · 2019 to 2026
$6.6M
Dynamics Of Ligand Gated Ion ChannelsR35GM122528 · NIGMS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI Vasanthi Jayaraman · 2017 to 2026
$6.2M
NMDAR Mutations & Neurodevelopmental Disorder: from Mechanism to Targeted TherapyR01HD082373 · NICHD · EMORY UNIVERSITY · PI YUAN, HONGJIE · 2015 to 2025
$3.3M
Human GRIA variants and neurological diseases: from molecular mechanism to rescue pharmacologyR21MH127404 · NIMH · EMORY UNIVERSITY · PI YUAN, HONGJIE · 2021 to 2022
$430k
NICHD NIH HHS R01 HD082373NIGMS NIH HHS R35 GM122528NIGMS NIH HHS T32 GM008280NIMH NIH HHS R21 MH127404NINDS NIH HHS R35 NS111619
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

channelopathyGluN1intellectual disabilitymolecular dynamicsmovement disorderNMDARpositive modulatorstranslational study

Identifiers

PMID34413877
PMCPMC8369916
OpenAlexW3191020476

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.